Literature DB >> 19639678

Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy.

Ana V Villar1, Miguel Llano, Manuel Cobo, Víctor Expósito, Ramón Merino, Rafael Martín-Durán, María A Hurlé, J Francisco Nistal.   

Abstract

Gender influence on left ventricular (LV) remodeling associated to aortic valve stenosis (AS) has been long recognized, but underlying myocardial gene expression patterns have not been explored. We studied whether sex differences in echocardiographic LV anatomy and function in AS patients are associated with specific changes in myocardial mRNA expression of remodeling proteins. AS (n=39) and control (n=23)patients were assessed echocardiographically, and LV myocardial mRNA levels were quantified by PCR. AS patients exhibit increased wall thicknesses and LV mass index (LVMI), but only men show chamber dilation.Collagens and fibronectin mRNA levels increased correlatively to transforming growth factor-beta1 (TGF-beta1). In AS women, collagen I upregulation was proportionally higher than other extracellular matrix (ECM)components. No changes in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 were detected. Gene expressions of sarcomeric proteins (beta-myosin heavy chain and myosin light chain-2) and TGF-beta1 were directly correlated with each other. Myosin light chain-2 mRNA levels increased proportionally to the transvalvular gradient, but women did so in a greater extent than men for a given gradient. In women, the hypertrophic growth response, reflected by LVMI, was proportional to the expression of genes encoding sarcomeric proteins and TGF-beta1. In men, chamber dilation and deterioration of LVEF was proportional to collagens, fibronectin, and TGF-beta1 gene expression levels. We evidenced gender biased gene expression patterns of the intracellular TGF-beta pathways involving the Smad branch, but not the TAK-1 branch, that could contribute to the remodeling differences observed in AS men and women. Based on these findings, a gender specific therapeutic approach of pressure overload LV hypertrophy could be justified.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19639678     DOI: 10.1016/j.yjmcc.2008.12.024

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  36 in total

1.  Aortic root remodeling and risk of heart failure in the Framingham Heart study.

Authors:  Carolyn S P Lam; Philimon Gona; Martin G Larson; Jayashri Aragam; Douglas S Lee; Gary F Mitchell; Daniel Levy; Susan Cheng; Emelia J Benjamin; Ramachandran S Vasan
Journal:  JACC Heart Fail       Date:  2013-02       Impact factor: 12.035

Review 2.  Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis.

Authors:  Sarah R Anthony; Adrienne R Guarnieri; Anamarie Gozdiff; Robert N Helsley; Albert Phillip Owens; Michael Tranter
Journal:  Clin Sci (Lond)       Date:  2019-11-29       Impact factor: 6.124

Review 3.  Clinical Implications of Serum Biomarkers of Cardiac Stress in Aortic Stenosis.

Authors:  Nimesh Patel; Dharam J Kumbhani
Journal:  Curr Heart Fail Rep       Date:  2018-10

4.  Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signature.

Authors:  William M Yarbrough; Rupak Mukherjee; Robert E Stroud; William T Rivers; J Marshall Oelsen; Jennifer A Dixon; Shaina R Eckhouse; John S Ikonomidis; Michael R Zile; Francis G Spinale
Journal:  J Thorac Cardiovasc Surg       Date:  2011-11-04       Impact factor: 5.209

Review 5.  Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications.

Authors:  William M Yarbrough; Rupak Mukherjee; John S Ikonomidis; Michael R Zile; Francis G Spinale
Journal:  J Thorac Cardiovasc Surg       Date:  2011-07-16       Impact factor: 5.209

Review 6.  Changes in the myocardial interstitium and contribution to the progression of heart failure.

Authors:  Shaina R Eckhouse; Francis G Spinale
Journal:  Heart Fail Clin       Date:  2012-01       Impact factor: 3.179

7.  Functional brown adipose tissue limits cardiomyocyte injury and adverse remodeling in catecholamine-induced cardiomyopathy.

Authors:  Robrecht Thoonen; Laura Ernande; Juan Cheng; Yasuko Nagasaka; Vincent Yao; Alexandre Miranda-Bezerra; Chan Chen; Wei Chao; Marcello Panagia; David E Sosnovik; Dheeraj Puppala; Antonis A Armoundas; Allyson Hindle; Kenneth D Bloch; Emmanuel S Buys; Marielle Scherrer-Crosbie
Journal:  J Mol Cell Cardiol       Date:  2015-05-09       Impact factor: 5.000

8.  Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice.

Authors:  Camille L Birch; Samantha M Behunin; Marissa A Lopez-Pier; Christiane Danilo; Yulia Lipovka; Chandra Saripalli; Henk Granzier; John P Konhilas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

Review 9.  What we know and do not know about sex and cardiac disease.

Authors:  John P Konhilas
Journal:  J Biomed Biotechnol       Date:  2010-04-22

10.  The Relationship between the Transforming Growth Factor β1 T29C Gene Polymorphism and Left Ventricular Geometry and Function in Hypertensive Subjects.

Authors:  Rosario Scaglione; Christiano Argano; Giovanni Duro; Tiziana Di Chiara; Domenico Nuzzo; Daniela Colomba; Maria Cristina Fiore; Salvatore Corrao; Giuseppe Licata
Journal:  Int J Hypertens       Date:  2010-03-23       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.